Rethinking Early-Stage

Biotech Investment.Biotech Investment.

We specialize in Seed and Series A funding across the U.S., UK, and Europe, identifying transformative technologies poised to address unmet needs in large markets. Our differentiated model goes beyond capital—partnering closely with founders to build strong teams, establish IP, and achieve milestones that attract follow-on funding.

A technology-first approach.

We prioritize groundbreaking solutions over executive rosters, collaborating with founders to develop the best teams and strategies.

Investing off the beaten path.

Leveraging a deep network of advisors and a first-principles approach, we uncover disruptive opportunities others overlook.

Focused research and valuable networks.

A seasoned network of advisers not only helps our team identify standout ideas but also creates a supportive ecosystem around our founders, enabling biological solutions to grow into scalable companies.

Deep technical and IP expertise.

Our hands-on approach helps founders secure milestones, establish strong IP, and attract follow-on investor capital.

OMX Ventures is more than just an investor; they are a strategic partner deeply rooted in life sciences and intellectual property expertise. Their team integrates seamlessly with ours, providing invaluable guidance on our capital journey, company strategy, and future direction. Beyond their advisory role, they serve as enthusiastic supporters, celebrating our successes and bolstering our resolve during challenging times.

Ola Wlodek, CEO

Constructive Bio

The OMX team brings a rare combination of not only top notch professional, but personal, support that helps their founders feel like they have mutually trusted, empowered, and appreciated relationships.

Mark Rus, CEO